Seems like one of these companies has to make it big and end up doubling from it's current position. Or maybe not. I'm just curious if anybody is really bullish on any of these names and what their bullish thesis is. I have to imagine one of these comes out a winner, but who? Illumnia (ILMN) is by far is the biggest market cap of the bunch at just below 17 billion. Crispr Therapeutics (CRSP) is about 3.5 billion, and it just goes down from there. You have Invitae which might be headed for bankruptcy? at a mere 151 million.
If anybody has any insight on any of these, or other companies that should be added to this mix, please elaborate:
- Illumnia (ILMN) 16.805B
- CRISPR Therapeutics AG (CRSP) 3.444B
- Intellia Therapeutics (NTLA) 2.219B
- Beam Therapeutics (BEAM) 1.644B
- Pacific Biosciences (PACB) 1.452B
- Twist Biosciences (TWST) 890.788M
- Editas Medicine Inc. (EDIT) 551.836M
- INVITAE CORPORATION (NVTA) 151.236M
Leave a Reply